These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combined test of hypothalamic-pituitary function in growth-retarded children treated with growth hormone. II. Secretion of LH, FSH, TSH, prolactin and ACTH. Eskildsen PC; Jacobsen BB; Kastrup KW; Krabbe S; Lebech PE; Petersen KE Acta Paediatr Scand Suppl; 1979; 277():14-20. PubMed ID: 232353 [TBL] [Abstract][Full Text] [Related]
3. Role of arginine vasopressin in control of ACTH and LH release during stress. Ono N; Bedran de Castro J; Khorram O; McCann SM Life Sci; 1985 May; 36(18):1779-86. PubMed ID: 2984509 [TBL] [Abstract][Full Text] [Related]
4. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas. Li GM; Sun XJ; Shao P Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136 [TBL] [Abstract][Full Text] [Related]
6. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats. Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772 [TBL] [Abstract][Full Text] [Related]
7. Congenital hypopituitarism associated with neonatal hypoglycemia and microphallus: four cases secondary to hypothalamic hormone deficiencies. Lovinger RD; Kaplan SL; Grumbach MM J Pediatr; 1975 Dec; 87(6 Pt 2):1171-81. PubMed ID: 1185416 [TBL] [Abstract][Full Text] [Related]
8. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449 [TBL] [Abstract][Full Text] [Related]
9. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. Korbonits M; Kaltsas G; Perry LA; Putignano P; Grossman AB; Besser GM; Trainer PJ J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825 [TBL] [Abstract][Full Text] [Related]
10. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309 [TBL] [Abstract][Full Text] [Related]
11. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone. Tilbrook AJ; Canny BJ; Stewart BJ; Serapiglia MD; Clarke IJ J Endocrinol; 1999 Aug; 162(2):301-11. PubMed ID: 10425469 [TBL] [Abstract][Full Text] [Related]
12. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Thomas GB; Fairhall KM; Robinson IC Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719 [TBL] [Abstract][Full Text] [Related]
13. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217 [TBL] [Abstract][Full Text] [Related]
14. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men. Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL Horm Res; 1976; 7(1):1-10. PubMed ID: 793974 [TBL] [Abstract][Full Text] [Related]
15. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Filipsson H; Johannsson G Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S85-95. PubMed ID: 19684055 [TBL] [Abstract][Full Text] [Related]
16. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067 [TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone replacement therapy on pituitary hormone secretion and hormone replacement therapies in GHD adults. Hubina E; Mersebach H; Rasmussen AK; Juul A; Sneppen SB; Góth MI; Feldt-Rasmussen U Horm Res; 2004; 61(5):211-7. PubMed ID: 14752209 [TBL] [Abstract][Full Text] [Related]
19. Effects of tri-iodothyronine, thyroxine and isopropyl-di-iodothyronine on thyroid-stimulating hormone in serum and pituitary gland and on pituitary concentrations of prolactin, growth hormone, luteinizing hormone and follicle-stimulating hormone in hypothyroid rats. Wong CC; Döhler KD; von zur Mühlen A J Endocrinol; 1980 Nov; 87(2):255-63. PubMed ID: 6776220 [TBL] [Abstract][Full Text] [Related]